Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...
The Manila Times

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to ...
Drug Target Review

Peptides in practice: what it takes to advance these therapies to clinic

Learn how therapies to clinic are evolving with peptide medicines, offering new solutions for oncology and metabolic ...
gadgets360

Vivo X300, Vivo X300 Pro Go on Sale in India Alongside Telephoto Extender Kit: Price, Offers, Features

Vivo X300 and Vivo X300 Pro are now on sale in India via online and offline channels. The standar X300 starts at Rs. 75,999, while the X300 Pro is priced at Rs. 1,09,999. Buyers can avail 10 percent ...
Frontiers

Off-target autophagy disruption associated with a novel liver toxicity in dogs for a highly basic heterobifunctional protein degrader

Introduction: The observation of hepatobiliary toxicity in a repeat-dose Good Laboratory Practice-compliant dog toxicology study was a primary driver for the deprioritization of a preclinical ...
The American Journal of Managed Care

In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients

In vivo CAR T-cell therapy could revolutionize cancer treatment by bypassing traditional manufacturing, reducing costs, and minimizing adverse events. Kelonia Therapeutics' KLN-1010 has shown ...
gadgets360

Vivo S50, Vivo S50 Pro Mini Launch Date Announced; Colour Options Revealed

Vivo has already started taking pre-orders for the Vivo S50 series Vivo S50 is teased to feature a 50-megapixel camera Vivo S50 Pro Mini will pack LPDDR5X RAM ...
BioSpace

Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin’s Lymphoma at the 2025 ASH Annual Meeting

SHANGHAI, Dec. 6, 2025 /PRNewswire/ -- Vivacta Bio, a spin-off company of Grit Biotherapeutics advancing in vivo CAR-T therapies for oncology and autoimmune diseases, today announced encouraging ...